SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-019876
Filing Date
2007-03-16
Accepted
2007-03-16 13:34:21
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a07-5600_110k.htm 10-K 1323686
2 EX-10.39 a07-5600_1ex10d39.htm EX-10.39 436666
3 EX-10.40 a07-5600_1ex10d40.htm EX-10.40 202709
4 EX-23.1 a07-5600_1ex23d1.htm EX-23.1 9494
5 EX-31.1 a07-5600_1ex31d1.htm EX-31.1 9778
6 EX-31.2 a07-5600_1ex31d2.htm EX-31.2 9917
7 EX-32.1 a07-5600_1ex32d1.htm EX-32.1 5682
8 EX-32.2 a07-5600_1ex32d2.htm EX-32.2 5695
9 GRAPHIC g56001dci001.gif GRAPHIC 7956
  Complete submission text file 0001104659-07-019876.txt   2016160
Mailing Address 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21243 | Film No.: 07699157
SIC: 2835 In Vitro & In Vivo Diagnostic Substances